AI-generated summary
The authors report a feasibility study in a pediatric hematology-oncology unit, applying photobiomodulation with two wavelengths to children with grade 2 or higher oral mucositis. Among 22 enrolled patients (median age 8.6 years), the procedure was reported as feasible and well tolerated, with pain relief and improved mucositis scores. The study was a feasibility study with no control group described in the abstract.
- Participants
- 22
- Who or what was studied
- Children with grade 2 or higher oral mucositis in a pediatric hematology-oncology unit (median age 8.6 years)
- Wavelengths
- 635, 815 nm
- Limits stated in the abstract
- The abstract describes a feasibility study without a control group, so the reported pain and mucositis improvements cannot be attributed to the laser alone.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 815nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Laser, GRADE, Visual analogue scale. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.